Timing between rituximab and 90Y-ibritumomab tiuxetan in pts with Non-Hodgkin's lymphoma does not affect clinical outcomes.

被引：0
|
作者：
Friedman, Isaiah E.
Andreadis, Charalambos
Diangi, Yumi Taylor
Nasta, Sunita D.
Luger, Selina M.
Stadtmauer, Edward A.
Schuster, Stephen J.
机构：
[1] Univ Penn, Sch Med, Philadelphia, PA 19104 USA
[2] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4735
引用
收藏
页码：267B / 267B
页数：1
相关论文
共 50 条
  • [1] Use of 90Y-ibritumomab tiuxetan in non-Hodgkin's lymphoma
    Marcus, R
    SEMINARS IN ONCOLOGY, 2005, 32 (01) : S36 - S43
  • [2] RIT WITH 90Y-IBRITUMOMAB TIUXETAN IMPROVES THE RESPONSE IN AGGRESSIVE NON-HODGKIN LYMPHOMA
    Montes Limon, A.
    Andrade Campos, M.
    Murillo Flores, I.
    Grasa Ulrich, J. M.
    Lievano, P.
    Baringo, T.
    Giraldo Castellanos, P.
    HAEMATOLOGICA, 2012, 97 : 667 - 668
  • [3] 90Y-ibritumomab tiuxetan:: Rationale for patient selection in the treatment of indolent non-Hodgkin's lymphoma
    Grillo-López, AJ
    SEMINARS IN ONCOLOGY, 2005, 32 (01) : S44 - S49
  • [4] 90Y-ibritumomab tiuxetan therapy of follicular non-Hodgkin's lymphoma: the experience in our hospital
    Ramal Leiva, D.
    Sabate-Llobera, A.
    Mercadal Vilchez, S.
    Garcia Munoz, N.
    Roca Engronyat, M.
    Mora Salvado, J.
    Martin-Comin, J.
    Gonzalez-Barca, E.
    Ricart Brulles, Y.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S429 - S429
  • [5] SINGLE CENTER EXPERIENCE OF 90Y-IBRITUMOMAB TIUXETAN IN THE OLDER POPULATION WITH NON-HODGKIN LYMPHOMA
    Agrawal, V.
    Castillo, J.
    Raup, K.
    Girton, T.
    Collins, S.
    Brady, J.
    Vadakara, J.
    Khan, S.
    HAEMATOLOGICA, 2016, 101 : 481 - 482
  • [6] Impact of Rituximab Treatment on 90Y-Ibritumomab Dosimetry for Patients with Non-Hodgkin Lymphoma
    Shen, Sui
    Forero, Andres
    Meredith, Ruby F.
    Shah, Jatin J.
    Knox, Susan J.
    Wiseman, Gregory A.
    Usrey, Marc E.
    LoBuglio, Albert F.
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51 (01) : 150 - 157
  • [7] Diagnostic imaging prior to 90Y-ibritumomab tiuxetan (Zevalin®) treatment in follicular non-Hodgkin's lymphoma
    Otte, Andreas
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2008, 11 (01): : 12 - 15
  • [8] Single center experience of 90Y-Ibritumomab tiuxetan in the older population with non-hodgkin lymphoma.
    Agrawal, Vaibhav
    Castillo, Jose Isaac
    Raup, Kelly
    Girton, Treanna
    Collins, Scott R.
    Brady, James O.
    Khan, Sharif S.
    Vadakara, Joseph
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [9] RADIOIMMUNOTHERAPY CASES REGISTRY: RECURRENT OR REFRACTORY NON-HODGKIN LYMPHOMA TREATED WITH 90Y-IBRITUMOMAB TIUXETAN
    Gomez-Codina, J.
    Giraldo, P.
    ANNALS OF ONCOLOGY, 2008, 19 : 232 - 232
  • [10] Experience with 90Y-ibritumomab tiuxetan for relapsed classical Hodgkin lymphoma
    Younes, A.
    Wong, F.
    ANNALS OF ONCOLOGY, 2009, 20 (06) : 1147 - 1148
12345